HUC3-637 for Open-Angle Glaucoma or High Eye Pressure
Tests HUC3-637 in adults with open-angle glaucoma or high eye pressure.
Plain-language title generated from the registry record
Registry title: Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Key facts
- Where
- Seoul, South KoreaSee the site
- Phase
- Phase 3
Where in South Korea
- Kangbuk Samsung HospitalSeoul, South KoreaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Huons Co., Ltd.
- Trial code
- NCT07335211
- Record updated
- 13 January 2026
- Original description
A multicenter, randomized, single-blind, active controlled, phase III clinical trial to evaluate the efficacy and safety of HUC3-637 in patients with primary open angle glaucoma or ocular hypertensionRead full original descriptionShow less
A Multicenter, Randomized, Single-blind, Active Controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A multicenter, randomized, single-blind, active controlled, phase III clinical trial to evaluate the efficacy and safety of HUC3-637 in patients with primary open angle glaucoma or ocular hypertension
Inclusion: Adults aged 19 years and older; Participants diagnosed with POAG or OH; Have fully explained and understood the study and have voluntarily given written informed consent.
Exclusion: Acute or chronic angle-closure glaucoma; Congenital glaucoma, secondary glaucoma (open-angle glaucoma).